Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus

Yun-Mi Song1, Joohon Sung, Soonha Yang

  • 1Department of Family Medicine, Samsung Medical Center, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, 50 Irwondong, Gangnamgu, Seoul, South Korea. ymsong@smc.samsung.co.kr

Insights

Hepatitis B virus (HBV) immunoprophylaxis failure in newborns can occur, particularly when mothers are HBeAg-positive or have detectable HBV DNA. Assessing these maternal factors before childbirth is crucial for identifying high-risk infants.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Perinatal transmission of Hepatitis B virus (HBV) persists despite immunoprophylaxis.
  • Understanding factors contributing to immunoprophylaxis failure is essential for preventing HBV infection in newborns.

Purpose of the Study:

  • To evaluate factors associated with the failure of Hepatitis B virus (HBV) immunoprophylaxis in infants born to HBsAg-seropositive mothers.
  • To identify specific maternal markers that predict immunoprophylaxis failure.

Main Methods:

  • A cohort of 144 infants born to HBsAg-seropositive mothers received standard HBV immunoprophylaxis (HB immune globulin and HB vaccine).
  • Infants were monitored for HBsAg-seropositivity, indicating immunoprophylaxis failure.
  • Maternal HBeAg and HBV DNA status were assessed.

Main Results:

  • Overall immunoprophylaxis failure rate was 11.8% (17 out of 144 infants).
  • Failure rates were significantly higher in infants born to mothers who were HBeAg-seropositive (21%) and HBV DNA seropositive (27%).
  • Maternal HBeAg and HBV DNA positivity were significantly associated with HBV immunoprophylaxis failure.

Conclusions:

  • Maternal HBeAg and HBV DNA status are critical predictors of HBV immunoprophylaxis failure in infants.
  • Assessing maternal HBeAg and HBV DNA prior to childbirth can help identify infants at high risk for HBV infection.
  • Targeted interventions may be necessary for high-risk neonates to improve HBV prevention efficacy.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...